Tenon Medical (TNON) Preferred Stock Liabilities (2021 - 2022)

Tenon Medical's (TNON) quarterly Preferred Stock Liabilities came in at $1.3 million in Q1 2022, little changed quarter-over-quarter from $1.3 million in Q4 2021.

Tenon Medical (TNON) Preferred Stock Liabilities (2021 - 2022) Analysis & Trends

Tenon Medical's Preferred Stock Liabilities history runs 2 years deep, the most recent figure standing at $1.3 million for Q1 2022.

  • On a quarterly basis, Preferred Stock Liabilities changed N/A year-over-year to $1.3 million in Q1 2022; TTM through Mar 2022 was $1.3 million, a N/A change from a year earlier, with the FY2021 full-year figure at $1.3 million, changed N/A from the prior year.
  • Preferred Stock Liabilities steadied at $1.3 million in Q1 2022 per TNON's latest filing, from $1.3 million in the prior quarter.
  • Across five years, Preferred Stock Liabilities topped out at $1.3 million in Q4 2021 and bottomed at $1.3 million in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Tenon Medical 719.40 -4.61 Mn 945,000.00 -

Historic Data

Download Data
DateValue
Mar 31, 2022 1.27 Mn
Dec 31, 2021 1.27 Mn